Advanced
  Home Compare Reports

Comparison with Similar Reports

Lateral Flow Assays Market by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker L...

by Application (Clinical Testing (Pregnancy, Infectious Diseases (Mosquito, Influenza, STI, Hepatitis, TB) Cardiac Marker Lipid Test) Veterinary, Food Safety), Product, Technique, End User

Publisher:        MarketsandMarkets

# of Pages:        333

Rating: 

1 User License $4,950

Publication Date:  November, 2020

Price:       $4,950 / User License




TABLE OF CONTENTS

 

1              INTRODUCTION                44

1.1          OBJECTIVES OF THE STUDY          44

1.2          MARKET DEFINITION      44

1.2.1      CATEGORY-WISE INCLUSIONS AND EXCLUSIONS IN THE LATERAL FLOW ASSAYS MARKET              44

1.3          MARKET SCOPE                45

1.3.1      MARKETS COVERED        45

1.3.2      YEARS CONSIDERED FOR THE STUDY        46

1.4          CURRENCY          46

1.4.1      EXCHANGE RATES UTILIZED FOR CONVERSION TO USD  46

1.5          LIMITATIONS     46

1.6          STAKEHOLDERS 47

1.7          SUMMARY OF CHANGES              47

2              RESEARCH METHODOLOGY         49

2.1          RESEARCH APPROACH   49

2.1.1      RESEARCH DESIGN          49

2.1.2      SECONDARY DATA           49

2.1.2.1   Key data from secondary sources             50

2.1.3      PRIMARY DATA 51

2.1.3.1   Primary sources                51

2.1.3.2   Key data from primary sources  52

2.1.3.3   Breakdown of primaries               52

FIGURE 1             BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                52

2.2          MARKET SIZE ESTIMATION          53

FIGURE 2             MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)    53

FIGURE 3             MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2019)    54

FIGURE 4             SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAYS MARKET (2019)                54

FIGURE 5             APPROACH 3: DEMAND-SIDE APPROACH, BASED ON THE MALARIA LATERAL FLOW TESTING MARKET SIZE (2019)   55

FIGURE 6             CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS OF THE LATERAL FLOW ASSAYS MARKET (2019)       56

FIGURE 7             CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE LATERAL FLOW ASSAYS MARKET (2020–2025)             57

2.3          MARKET BREAKDOWN & DATA TRIANGULATION              58

FIGURE 8             DATA TRIANGULATION METHODOLOGY               58

2.4          MARKET SHARE ESTIMATION     59

2.5          ASSUMPTIONS FOR THE STUDY 59

2.6          COVID-19 HEALTH ASSESSMENT                60

2.7          COVID-19 ECONOMIC ASSESSMENT        60

2.8          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO          61

FIGURE 9             CRITERIA IMPACTING THE GLOBAL ECONOMY    61

2.9          ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAYS MARKET                63

3              EXECUTIVE SUMMARY  64

FIGURE 11           LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2020 VS. 2025 (USD MILLION)     64

FIGURE 12           LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,

2020 VS. 2025 (USD MILLION)     65

FIGURE 13           LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 

2020 VS. 2025 (USD MILLION)     65

FIGURE 14           CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 

2020 VS. 2025 (USD MILLION)     66

FIGURE 15           LATERAL FLOW ASSAYS MARKET, BY END USER,

2020 VS. 2025 (USD MILLION)     67

FIGURE 16           GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAYS MARKET       68

4              PREMIUM INSIGHTS       69

4.1          LATERAL FLOW ASSAYS MARKET OVERVIEW        69

FIGURE 17           RISING COVID-19 PATIENT POPULATION AND GROWTH IN THE PREVALENCE OF INFECTIOUS DISEASES IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET                69

4.2          REGIONAL MIX: LATERAL FLOW ASSAYS MARKET              70

FIGURE 18           APAC TO REGISTER THE HIGHEST CAGR OF 7.0% DURING THE FORECAST PERIOD               70

4.3          LATERAL FLOW ASSAYS MARKET: DEVELOPED VS. DEVELOPING MARKETS             70

FIGURE 19           DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING THE FORECAST PERIOD                70

5              MARKET OVERVIEW       71

5.1          INTRODUCTION                71

FIGURE 20           LATERAL FLOW ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES     71

5.2          MARKET DYNAMICS: IMPACT ANALYSIS                72

5.2.1      MARKET DRIVERS            72

5.2.1.1   High prevalence of infectious diseases across the globe 72

FIGURE 21           PREVALENCE OF INFECTIOUS DISEASES WORLDWIDE      73

TABLE 1                PREVALENCE OF HIV WORLDWIDE (2017 VS. 2019)            73

5.2.1.2   Rapidly increasing geriatric population    74

FIGURE 22           GERIATRIC POPULATION, BY REGION, 2019 VS. 2030 (MILLION)  74

FIGURE 23           GERIATRIC POPULATION, BY COUNTRY, 2010 VS. 2019 (MILLION)              74

5.2.1.3   Growing usage of home-based lateral flow assay devices             75

5.2.1.4   Growing demand for point-of-care testing           75

5.2.1.5   Need for rapid diagnostic testing for COVID-19  76

FIGURE 24           NUMBER OF CONFIRMED CASES OF COVID-19, BY WHO REGION (MILLION)         76

5.2.2      MARKET RESTRAINTS     76

5.2.2.1   Reluctance towards changing existing diagnostic practices            76

5.2.2.2   Lower accuracy of lateral flow assay tests             77

5.2.3      MARKET OPPORTUNITIES            77

5.2.3.1   Evolving applications of lateral flow assays           77

TABLE 2                LIST OF COMMERCIALLY AVAILABLE SALIVA LFA PRODUCTS         77

5.2.3.2   Rising demand for lateral flow assays in the food & beverage industry    78

5.2.4      CHALLENGES      78

5.2.4.1   Limited reimbursements for lateral flow assay products                78

5.2.4.2   Difficulties in procuring quality raw materials for the development of lateral flow assay tests       79

5.3          PORTER’S FIVE FORCES ANALYSIS             79

TABLE 3                LATERAL FLOW ASSAYS MARKET: PORTER’S FIVE FORCES ANALYSIS          80

5.3.1      THREAT FROM NEW ENTRANTS 80

5.3.2      THREAT FROM SUBSTITUTES       81

5.3.3      BARGAINING POWER OF SUPPLIERS       81

5.3.4      BARGAINING POWER OF BUYERS             81

5.3.5      INTENSITY OF COMPETITIVE RIVALRY     81

5.4          AVERAGE SELLING PRICE TREND               82

TABLE 4                AVERAGE SELLING PRICE OF LATERAL FLOW ANALYZERS, BY REGION,

2015 VS. 2020     82

5.5          VALUE CHAIN ANALYSIS               82

FIGURE 25           LATERAL FLOW ASSAYS MARKET: VALUE CHAIN ANALYSIS (2019)              83

5.6          ECOSYSTEM MAP             83

FIGURE 26           ECOSYSTEM: LATERAL FLOW ASSAYS MARKET (2019)       83

5.7          TECHNOLOGY ANALYSIS               85

5.7.1      KEY TECHNOLOGY: LATERAL FLOW ASSAYS           85

5.7.2      ADJACENT TECHNOLOGY: ELISA (ENZYME-LINKED IMMUNOSORBENT ASSAYS)  85

5.8          COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET         85

6              INDUSTRY INSIGHTS       87

6.1          INTRODUCTION                87

6.2          INDUSTRY TRENDS          87

6.2.1      INTEGRATION OF MICROFLUIDIC TECHNOLOGY  IN LATERAL FLOW ASSAYS          87

6.2.2      DEMAND FOR QUANTITATIVE RESULTS 88

TABLE 5                MANUFACTURERS AND MODELS OF OPTICAL DETECTORS FOR RECORDING IMMUNOCHROMATOGRAPHY RESULTS               88

TABLE 6                EXAMPLES OF SMARTPHONE/MOBILE PHONE-BASED QUANTITATIVE LATERAL FLOW ASSAYS AND THEIR TARGET ANALYTES          89

6.2.3      RISING DEMAND FOR MULTIPLEXED LATERAL FLOW BIOSENSORS             89

6.2.4      NANOPARTICLE-BASED LATERAL FLOW ASSAYS 90

6.3          REGULATORY ANALYSIS                90

TABLE 7                REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION          90

6.3.1      NORTH AMERICA             90

6.3.2      EUROPE               91

6.3.3      ASIA      92

6.3.3.1   India      92

6.3.3.2   China     92

6.3.3.3   Japan    92

6.4          COMPONENT ANALYSIS FOR LATERAL FLOW ASSAY KITS               92

6.4.1      MEMBRANES     92

6.4.1.1   Nitrocellulose membranes          93

6.4.1.2   Other membranes          93

6.4.2      PADS     94

6.4.2.1   Conjugate pads                94

6.4.2.2   Absorbent pads                94

7              LATERAL FLOW ASSAYS MARKET, BY PRODUCT   95

7.1          INTRODUCTION                96

TABLE 8                LATERAL FLOW ASSAYS MARKET, BY PRODUCT, 2018–2025 (USD MILLION)           96

7.2          KITS & REAGENTS            96

7.2.1      INCREASING DEMAND FOR POC TESTING IS DRIVING THE DEMAND FOR KITS & REAGENTS IN THE LATERAL FLOW ASSAYS MARKET              96

TABLE 9                LATERAL FLOW KITS & REAGENTS MARKET, BY COUNTRY,

 2018–2025 (USD MILLION)          97

7.3          LATERAL FLOW READERS              97

TABLE 10              EXAMPLES OF LATERAL FLOW READERS AVAILABLE IN THE MARKET         97

TABLE 11              LATERAL FLOW READERS MARKET, BY TYPE, 2018–2025 (USD MILLION)   98

TABLE 12              LATERAL FLOW READERS MARKET, BY COUNTRY, 2018–2025 (USD MILLION)        99

7.3.1      DIGITAL/HANDHELD READERS    99

7.3.1.1   Technological advancements and high accuracy are the major factors driving the growth of the digital/handheld readers market 99

TABLE 13              DIGITAL/HANDHELD LATERAL FLOW READERS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)             100

7.3.2      BENCHTOP READERS      100

7.3.2.1   Lower diagnosis cost per patient is driving the benchtop readers market               100

TABLE 14              BENCHTOP LATERAL FLOW READERS MARKET, BY COUNTRY,

2020–2025 (USD MILLION)           101

7.3.3      MOBILE/SMARTPHONE READERS             101

7.3.3.1   Low cost, convenience, and user-friendliness are major factors driving the growth of the mobile/smartphone readers market 101

8              LATERAL FLOW ASSAYS MARKET, BY APPLICATION           102

8.1          INTRODUCTION                103

TABLE 15              LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          103

8.2          CLINICAL TESTING           103

TABLE 16              LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,

 BY TYPE,  2018–2025 (USD MILLION)       104

TABLE 17              LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,

 BY COUNTRY,  2018–2025 (USD MILLION)             104

8.2.1      INFECTIOUS DISEASE TESTING   105

TABLE 18              LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2018–2025 (USD MILLION)       105

TABLE 19              LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

 BY COUNTRY, 2018–2025 (USD MILLION)              106

8.2.1.1   Mosquito-borne diseases            106

8.2.1.1.1               Increasing incidence of dengue is driving the growth of the lateral flow assays market for mosquito-borne diseases               106

TABLE 20              MAJOR PRODUCTS: DENGUE TESTING   107

TABLE 21              LATERAL FLOW ASSAYS MARKET FOR MOSQUITO-BORNE DISEASES,

BY COUNTRY,  2018–2025 (USD MILLION)              108

8.2.1.2   COVID-19            108

8.2.1.2.1               The ongoing COVID-19 pandemic to drive the demand for rapid lateral flow tests              108

TABLE 22              COVID-19 (ANTIGEN AND ANTIBODY) LATERAL FLOW ASSAY TESTS (2020)             109

TABLE 23              LATERAL FLOW ASSAYS MARKET FOR COVID-19, BY COUNTRY,

 2018–2025 (USD MILLION)          110

8.2.1.3   Influenza             110

8.2.1.3.1               Growing prevalence of influenza globally is expected to boost the growth of the influenza testing market                110

TABLE 24              LATERAL FLOW ASSAYS MARKET FOR INFLUENZA, BY COUNTRY, 

2018–2025 (USD MILLION)           111

8.2.1.4   Sexually transmitted infections 111

TABLE 25              LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE,  2018–2025 (USD MILLION)             112

TABLE 26              LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY COUNTRY, 2018–2025 (USD MILLION)             113

8.2.1.4.1               HIV         113

8.2.1.4.1.1           Growing awareness about HIV POC testing is one of the major factors driving market growth     113

FIGURE 27           PATIENTS TREATED FOR HIV GLOBALLY, 2005–2019          114

TABLE 27              LATERAL FLOW ASSAYS MARKET FOR HIV, BY COUNTRY,

2018–2025 (USD MILLION)           115

8.2.1.4.2               HPV       115

8.2.1.4.2.1           Rising adoption of HPV testing to drive the market during the forecast period     115

TABLE 28              LATERAL FLOW ASSAYS MARKET FOR HPV, BY COUNTRY,

 2018–2025 (USD MILLION)          116

8.2.1.4.3               Chlamydia           116

8.2.1.4.3.1           Growing incidence of chlamydia and rising awareness among patients is driving the growth of this segment                116

TABLE 29              LATERAL FLOW ASSAYS MARKET FOR CHLAMYDIA, BY COUNTRY, 2018–2025        117

8.2.1.4.4               Gonorrhea          117

8.2.1.4.4.1           Rising incidence of gonorrhea globally and increased funding for R&D to drive the lateral flow assays market during the forecast period           117

TABLE 30              LATERAL FLOW ASSAYS MARKET FOR GONORRHEA, BY COUNTRY, 

2018–2025 (USD MILLION)           118

8.2.1.4.5               Syphilis 119

8.2.1.4.5.1           Growing adoption of novel technologies supporting the growth of the lateral flow assays market for syphilis testing  119

TABLE 31              NUMBER OF CASES OF SYPHILIS, BY COUNTRY, 2011–2018            119

TABLE 32              LATERAL FLOW ASSAYS MARKET FOR SYPHILIS, BY COUNTRY, 

2018–2025 (USD MILLION)           120

8.2.1.4.6               Other sexually transmitted infections     120

TABLE 33              LATERAL FLOW ASSAYS MARKET FOR OTHER SEXUALLY TRANSMITTED INFECTIONS,  BY COUNTRY, 2018–2025 (USD MILLION)       121

8.2.1.5   Hepatitis              121

8.2.1.5.1               Nucleic acid hybridization-based lateral flow assays hold great potential in the hepatitis testing market  121

TABLE 34              LATERAL FLOW ASSAYS MARKET FOR HEPATITIS, BY COUNTRY,

 2018–2025 (USD MILLION)          122

8.2.1.6   Tuberculosis       122

8.2.1.6.1               Rising prevalence of the disease and a growing focus on early diagnosis and treatment of tuberculosis is expected to drive this market    122

TABLE 35              LATERAL FLOW ASSAYS MARKET FOR TUBERCULOSIS, BY COUNTRY, 

2018–2025 (USD MILLION)           123

8.2.1.7   Other infectious diseases             123

TABLE 36              LATERAL FLOW ASSAYS MARKET FOR OTHER INFECTIOUS DISEASES,

 BY COUNTRY, 2018–2025 (USD MILLION)              124

8.2.2      CARDIAC MARKER TESTING         125

TABLE 37              LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018–2025 (USD MILLION)   125

TABLE 38              LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY COUNTRY,  2018–2025 (USD MILLION)              126

8.2.2.1   Troponin I and T testing                126

8.2.2.1.1               Introduction of high-sensitivity troponin assays to drive this market during the forecast period  126

TABLE 39              LATERAL FLOW ASSAYS MARKET FOR TROPONIN I AND T TESTING,

 BY COUNTRY,  2018–2025 (USD MILLION)             127

8.2.2.2   CK-MB testing   127

8.2.2.2.1               Growing applications of lateral flow tests in acute myocardial injuries to drive this market             127

TABLE 40              LATERAL FLOW ASSAYS MARKET FOR CK-MB TESTING, BY COUNTRY,

 2018–2025 (USD MILLION)          128

8.2.2.3   BNP and NT-proBNP testing        129

8.2.2.3.1               Increasing demand for cardiac biomarker tests to detect heart stress and damage to drive growth in this market 129

TABLE 41              LATERAL FLOW ASSAYS MARKET FOR BNP & NT-PROBNP TESTING,

BY COUNTRY,  2018–2025 (USD MILLION)              129

8.2.2.4   Myoglobin testing           130

8.2.2.4.1               Availability of new high-sensitivity cardiac troponin assays to restrict the growth of the routine myoglobin testing market  130

TABLE 42              LATERAL FLOW ASSAYS MARKET FOR MYOGLOBIN TESTING, BY COUNTRY,  2018–2025 (USD MILLION)    130

8.2.2.5   D-Dimer testing                131

8.2.2.5.1               Rising incidence of cardiovascular diseases globally is expected to drive the market for D-dimer tests      131

TABLE 43              LATERAL FLOW ASSAYS MARKET FOR D-DIMER TESTING, BY COUNTRY,  2018–2025 (USD MILLION)           131

8.2.2.6   Other cardiac markers   132

TABLE 44              LATERAL FLOW ASSAYS MARKET FOR OTHER CARDIAC MARKER TESTS,

BY COUNTRY, 2018–2025 (USD MILLION)               132

8.2.3      PREGNANCY & FERTILITY TESTING            133

TABLE 45              LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,

BY TYPE,  2018–2025 (USD MILLION)        133

TABLE 46              LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,

BY COUNTRY, 2018–2025 (USD MILLION)               134

8.2.3.1   Pregnancy testing            134

8.2.3.1.1               Pregnancy testing is among the most common application areas for lateral flow assays, registering slower growth during the forecast period           134

TABLE 47              LATERAL FLOW ASSAYS MARKET FOR PREGNANCY TESTING, BY COUNTRY,  2018–2025 (USD MILLION)    135

8.2.3.2   Fertility testing  135

8.2.3.2.1               Rising infertility rates across the globe driving the demand for POC fertility testing kits    135

TABLE 48              LATERAL FLOW ASSAYS MARKET FOR FERTILITY TESTING, BY COUNTRY,  2018–2025 (USD MILLION)           136

8.2.4      CHOLESTEROL TESTING/LIPID PROFILES 136

8.2.4.1   Growing prevalence of obesity and CVD is the key factor driving market growth                136

TABLE 49              LATERAL FLOW ASSAYS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILES,  BY COUNTRY, 2018–2025 (USD MILLION) 137

8.2.5      DRUGS-OF-ABUSE TESTING        137

8.2.5.1   Technological advancements and growing focus on workplace drug testing are driving market growth    137

TABLE 50              LATERAL FLOW ASSAYS MARKET FOR DRUGS-OF-ABUSE TESTING,

 BY COUNTRY,  2018–2025 (USD MILLION)             138

8.2.6      OTHER CLINICAL TESTS  139

TABLE 51              LATERAL FLOW ASSAYS MARKET FOR OTHER CLINICAL TESTS, BY COUNTRY,  2018–2025 (USD MILLION)  139

8.3          VETERINARY DIAGNOSTICS         139

8.3.1      INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH                139

TABLE 52              LATERAL FLOW ASSAYS MARKET FOR VETERINARY DIAGNOSTICS,

BY COUNTRY,  2018–2025 (USD MILLION)              140

8.4          FOOD SAFETY & ENVIRONMENT TESTING             141

8.4.1      HIGH SENSITIVITY AND EASE OF USE ARE DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING               141

TABLE 53              LATERAL FLOW ASSAYS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING,  BY COUNTRY, 2018–2025 (USD MILLION) 142

8.5          DRUG DEVELOPMENT & QUALITY TESTING          142

8.5.1      INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE IS DRIVING THE GROWTH OF THIS MARKET                142

TABLE 54              LATERAL FLOW ASSAYS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING,  BY COUNTRY, 2018–2025 (USD MILLION) 143

8.6          COVID-19 IMPACT ON THE LATERAL FLOW ASSAY APPLICATION MARKET              143

9              LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE            144

9.1          INTRODUCTION                145

TABLE 55              LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE, 

2018–2025 (USD MILLION)           145

9.2          SANDWICH ASSAYS         145

9.2.1      WIDE APPLICATIONS OF SANDWICH ASSAYS IN CLINICAL TESTING CONTRIBUTING TO THE LARGEST SHARE OF THIS SEGMENT            145

TABLE 56              LATERAL FLOW SANDWICH ASSAYS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           146

9.3          COMPETITIVE ASSAYS    147

9.3.1      REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER GROWTH          147

TABLE 57              LATERAL FLOW COMPETITIVE ASSAYS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           147

9.4          MULTIPLEX DETECTION ASSAYS 148

9.4.1      INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE THE GROWTH OF THIS MARKET                148

TABLE 58              LATERAL FLOW MULTIPLEX DETECTION ASSAYS MARKET, BY COUNTRY,  2018–2025 (USD MILLION)          148

10           CLINICAL TESTING LATERAL FLOW ASSAYS MARKET,  BY SAMPLE TYPE     149

10.1        INTRODUCTION                150

TABLE 59              CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)             150

10.2        BLOOD SAMPLES              150

10.2.1    INCREASING USE OF BLOOD SAMPLES FOR INFECTIOUS DISEASE TESTING TO DRIVE THE GROWTH OF THIS SEGMENT            150

TABLE 60              CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR BLOOD SAMPLES, BY COUNTRY, 2018–2025 (USD MILLION)             151

10.3        URINE SAMPLES               151

10.3.1    GROWING USE OF URINE SAMPLES FOR PREGNANCY TESTING AND DRUGS-OF-ABUSE TESTING TO DRIVE THE GROWTH OF THIS MARKET          151

TABLE 61              CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR URINE SAMPLES,

 BY COUNTRY,  2018–2025 (USD MILLION)             152

10.4        SALIVA SAMPLES             152

10.4.1    EASY AND LOW-COST COLLECTION, TRANSPORT, AND ANALYSIS OF SALIVA SAMPLES ARE THE KEY FACTORS DRIVING MARKET GROWTH        152

TABLE 62              CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR SALIVA SAMPLES, BY COUNTRY,  2018–2025 (USD MILLION)             153

10.5        OTHER SAMPLES              153

TABLE 63              CLINICAL TESTING LATERAL FLOW ASSAYS MARKET FOR OTHER SAMPLES,

 BY COUNTRY, 2018–2025 (USD MILLION)              154

11           LATERAL FLOW ASSAYS MARKET, BY END USER  155

11.1        INTRODUCTION                156

TABLE 64              LATERAL FLOW ASSAYS MARKET, BY END USER, 2018–2025 (USD MILLION)           156

11.2        HOSPITALS & CLINICS     156

11.2.1    INCREASING USE OF POC TESTS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS AMONG HOSPITALS & CLINICS                156

TABLE 65              LATERAL FLOW ASSAYS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,  2018–2025 (USD MILLION)     157

11.3        DIAGNOSTIC LABORATORIES      157

11.3.1    LABORATORY TESTING IS LARGELY PREFERRED OVER PROFESSIONAL SETTINGS FOR URINE AND BLOOD TESTING—A KEY FACTOR DRIVING MARKET GROWTH              157

TABLE 66              LATERAL FLOW ASSAYS MARKET FOR DIAGNOSTIC LABORATORIES,

BY COUNTRY,  2018–2025 (USD MILLION)              158

11.4        HOME CARE SETTINGS   158

11.4.1    GROWING ACCEPTANCE OF REMOTE MONITORING DRIVING THE GROWTH OF THE LATERAL FLOW ASSAYS MARKET FOR HOME CARE              158

TABLE 67              LATERAL FLOW ASSAYS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,  2018–2025 (USD MILLION)   159

11.5        PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES       160

11.5.1    INCREASING FOCUS ON PRODUCT SAFETY TO DRIVE THE USE OF LATERAL FLOW ASSAYS AMONG PHARMACEUTICAL & BIOTECH COMPANIES        160

TABLE 68              LATERAL FLOW ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018–2025 (USD MILLION)           160

11.6        OTHER END USERS           161

TABLE 69              LATERAL FLOW ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY,  2018–2025 (USD MILLION)           161

12           LATERAL FLOW ASSAYS MARKET, BY REGION      162

12.1        INTRODUCTION                163

FIGURE 28           US TO DOMINATE THE LATERAL FLOW ASSAYS MARKET DURING THE FORECAST PERIOD                163

TABLE 70              LATERAL FLOW ASSAYS MARKET, BY REGION, 2018–2025 (USD MILLION)               164

12.2        NORTH AMERICA             164

TABLE 71              NORTH AMERICA: MACROECONOMIC INDICATORS         165

FIGURE 29           NORTH AMERICA: LATERAL FLOW ASSAYS MARKET SNAPSHOT  165

TABLE 72              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 

2018–2025 (USD MILLION)           166

TABLE 73              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

 2018–2025 (USD MILLION)          166

TABLE 74              NORTH AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,

 2018–2025 (USD MILLION)          166

TABLE 75              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 

2018–2025 (USD MILLION)           167

TABLE 76              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)       167

TABLE 77              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION)           168

TABLE 78              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION)           168

TABLE 79              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,  BY TYPE, 2018–2025 (USD MILLION) 169

TABLE 80              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)       169

TABLE 81              NORTH AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

 BY TECHNIQUE,  2018–2025 (USD MILLION)         169

TABLE 82              NORTH AMERICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET,

BY SAMPLE TYPE, 2018–2025 (USD MILLION)       170

TABLE 83              NORTH AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER,

 2018–2025 (USD MILLION)          170

12.2.1    US          170

12.2.1.1                The US accounts for the largest share of the lateral flow assays market in North America               170

TABLE 84              US: MACROECONOMIC INDICATORS      171

TABLE 85              US: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           171

TABLE 86              US: LATERAL FLOW READERS MARKET, BY TYPE, 2018–2025 (USD MILLION)           172

TABLE 87              US: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          172

TABLE 88              US: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             172

TABLE 89              US: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

 BY DISEASE TYPE, 2018–2025 (USD MILLION)      173

TABLE 90              US: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION)             173

TABLE 91              US: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE,  2018–2025 (USD MILLION)        174

TABLE 92              US: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             174

TABLE 93              US: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)            174

TABLE 94              US: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)     175

TABLE 95              US: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 USD MILLION)             175

12.2.2    CANADA              175

12.2.2.1                Availability of research funding and implementation of favorable government initiatives are driving the market in Canada             175

TABLE 96              CANADA: MACROECONOMIC INDICATORS          176

TABLE 97              CANADA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           176

TABLE 98              CANADA: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           177

TABLE 99              CANADA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          177

TABLE 100            CANADA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018–2025 (USD MILLION)             177

TABLE 101            CANADA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION) 178

TABLE 102            CANADA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2020–2025 (USD MILLION) 178

TABLE 103            CANADA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION)             179

TABLE 104            CANADA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018–2025 (USD MILLION) 179

TABLE 105            CANADA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)                179

TABLE 106            CANADA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                180

TABLE 107            CANADA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           180

12.3        COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN NORTH AMERICA               180

12.4        EUROPE               181

TABLE 108            EUROPE: LATERAL FLOW ASSAYS MARKET, BY COUNTRY,

2018–2025 (USD MILLION)           181

TABLE 109            EUROPE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           181

TABLE 110            EUROPE: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           182

TABLE 111            EUROPE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           182

TABLE 112            EUROPE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018–2025 (USD MILLION)             182

TABLE 113            EUROPE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION) 183

TABLE 114            EUROPE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 183

TABLE 115            EUROPE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION)             184

TABLE 116            EUROPE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018–2025 (USD MILLION)             184

TABLE 117            EUROPE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION) 184

TABLE 118            EUROPE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                185

TABLE 119            EUROPE: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           185

12.4.1    GERMANY           185

12.4.1.1                Growing number of the POC diagnostics centers to drive the demand for lateral flow assays in Germany                185

TABLE 120            GERMANY: MACROECONOMIC INDICATORS       186

TABLE 121            GERMANY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           186

TABLE 122            GERMANY: LATERAL FLOW READERS MARKET, BY TYPE,

 2018–2025 (USD MILLION)          186

TABLE 123            GERMANY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          187

TABLE 124            GERMANY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018–2025 (USD MILLION) 187

TABLE 125            GERMANY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION)       188

TABLE 126            GERMANY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 188

TABLE 127            GERMANY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION)             189

TABLE 128            GERMANY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018–2025 (USD MILLION) 189

TABLE 129            GERMANY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

BY TECHNIQUE,  2018–2025 (USD MILLION)          189

TABLE 130            GERMANY: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)             190

TABLE 131            GERMANY: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           190

12.4.2    FRANCE                190

12.4.2.1                High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France                190

TABLE 132            FRANCE: MACROECONOMIC INDICATORS            191

TABLE 133            FRANCE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           191

TABLE 134            FRANCE: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           191

TABLE 135            FRANCE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           192

TABLE 136            FRANCE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018–2025 (USD MILLION)             192

TABLE 137            FRANCE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION) 193

TABLE 138            FRANCE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 193

TABLE 139            FRANCE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION)             194

TABLE 140            FRANCE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018–2025 (USD MILLION)             194

TABLE 141            FRANCE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION) 194

TABLE 142            FRANCE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                195

TABLE 143            FRANCE: LATERAL FLOW ASSAYS MARKET, BY END USER,

 2018–2025 (USD MILLION)          195

12.4.3    UK          195

12.4.3.1                Increasing incidence of chronic diseases and rising prevalence of obesity propelling the market growth in the UK  195

TABLE 144            UK: MACROECONOMIC INDICATORS      196

TABLE 145            UK: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           196

TABLE 146            UK: LATERAL FLOW READERS MARKET, BY TYPE, 2018–2025 (USD MILLION)          196

TABLE 147            UK: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           197

TABLE 148            UK: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             197

TABLE 149            UK: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2018–2025 (USD MILLION)       198

TABLE 150            UK: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION)             198

TABLE 151            UK: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE,  2018–2025 (USD MILLION)        199

TABLE 152            UK: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             199

TABLE 153            UK: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)            199

TABLE 154            UK: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)     200

TABLE 155            UK: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           200

12.4.4    ITALY     200

12.4.4.1                Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country    200

TABLE 156            ITALY: MACROECONOMIC INDICATORS 201

TABLE 157            ITALY: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           201

TABLE 158            ITALY: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           201

TABLE 159            ITALY: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           202

TABLE 160            ITALY: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             202

TABLE 161            ITALY: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 203

TABLE 162            ITALY: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 203

TABLE 163            ITALY: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE,  2018–2025 (USD MILLION)        204

TABLE 164            ITALY: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             204

TABLE 165            ITALY: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)       204

TABLE 166            ITALY: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                205

TABLE 167            ITALY: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           205

12.4.5    SPAIN   205

12.4.5.1                Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth    205

TABLE 168            SPAIN: MACROECONOMIC INDICATORS               206

TABLE 169            SPAIN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

 2018–2025 (USD MILLION)          206

TABLE 170            SPAIN: LATERAL FLOW READERS MARKET, BY TYPE,

 2018–2025 (USD MILLION)          206

TABLE 171            SPAIN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          207

TABLE 172            SPAIN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             207

TABLE 173            SPAIN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 208

TABLE 174            SPAIN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 208

TABLE 175            SPAIN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE,  2018–2025 (USD MILLION)        209

TABLE 176            SPAIN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             209

TABLE 177            SPAIN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)     209

TABLE 178            SPAIN: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                210

TABLE 179            SPAIN: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           210

12.4.6    REST OF EUROPE              210

TABLE 180            ROE: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

 2018–2025 (USD MILLION)          211

TABLE 181            ROE: LATERAL FLOW READERS MARKET, BY TYPE,

 2018–2025 (USD MILLION)          211

TABLE 182            ROE: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           211

TABLE 183            ROE: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             212

TABLE 184            ROE: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,

BY DISEASE TYPE, 2018–2025 (USD MILLION)       212

TABLE 185            ROE: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION)             213

TABLE 186            ROE: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

 BY TYPE,  2018–2025 (USD MILLION)       213

TABLE 187            ROE: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             213

TABLE 188            ROE: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)         214

TABLE 189            ROE: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)   214

TABLE 190            ROE: LATERAL FLOW ASSAYS MARKET, BY END USER,

 2018–2025 (USD MILLION)          214

12.5        COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN EUROPE 215

12.6        ASIA PACIFIC     215

FIGURE 30           ASIA PACIFIC: LATERAL FLOW ASSAYS MARKET SNAPSHOT           216

TABLE 191            APAC: LATERAL FLOW ASSAYS MARKET, BY COUNTRY

, 2018–2025 (USD MILLION)         216

TABLE 192            APAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           217

TABLE 193            APAC: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           217

TABLE 194            APAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          217

TABLE 195            APAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             218

TABLE 196            APAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 218

TABLE 197            APAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 219

TABLE 198            APAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE,  2018–2025 (USD MILLION)        219

TABLE 199            APAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             219

TABLE 200            APAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)      220

TABLE 201            APAC: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                220

TABLE 202            APAC: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           220

12.6.1    CHINA   221

12.6.1.1                Growing adoption of lateral flow assays in veterinary diagnostics and drug development is expected to drive the market growth in China             221

TABLE 203            CHINA: MACROECONOMIC INDICATORS               221

TABLE 204            CHINA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           222

TABLE 205            CHINA: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           222

TABLE 206            CHINA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          222

TABLE 207            CHINA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             223

TABLE 208            CHINA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 223

TABLE 209            CHINA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 224

TABLE 210            CHINA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

 BY TYPE, 2018–2025 (USD MILLION)        224

TABLE 211            CHINA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             224

TABLE 212            CHINA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)    225

TABLE 213            CHINA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                225

TABLE 214            CHINA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           225

12.6.2    JAPAN  226

12.6.2.1                Increasing prevalence of age-related illnesses driving the growth of the lateral flow assays market in Japan                226

TABLE 215            JAPAN: MACROECONOMIC INDICATORS              226

TABLE 216            JAPAN: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           227

TABLE 217            JAPAN: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           227

TABLE 218            JAPAN: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           227

TABLE 219            JAPAN: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             228

TABLE 220            JAPAN: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 228

TABLE 221            JAPAN: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 229

TABLE 222            JAPAN: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE, 2018–2025 (USD MILLION)         229

TABLE 223            JAPAN: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             229

TABLE 224            JAPAN: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)    230

TABLE 225            JAPAN: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                230

TABLE 226            JAPAN: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           230

12.6.3    INDIA    231

12.6.3.1                Increasing prevalence of chronic disorders, growing healthcare concerns, and rising income levels to propel the growth of this market            231

TABLE 227            INDIA: MACROECONOMIC INDICATORS                231

TABLE 228            INDIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           231

TABLE 229            INDIA: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           232

TABLE 230            INDIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          232

TABLE 231            INDIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             232

TABLE 232            INDIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 233

TABLE 233            INDIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 233

TABLE 234            INDIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE,  2018–2025 (USD MILLION)        234

TABLE 235            INDIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             234

TABLE 236            INDIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)      234

TABLE 237            INDIA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                235

TABLE 238            INDIA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           235

12.6.4    AUSTRALIA         235

12.6.4.1                Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assays market   235

TABLE 239            AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           236

TABLE 240            AUSTRALIA: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           236

TABLE 241            AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           236

TABLE 242            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018–2025 (USD MILLION) 237

TABLE 243            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION)       237

TABLE 244            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION)       238

TABLE 245            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION)             238

TABLE 246            AUSTRALIA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018–2025 (USD MILLION) 238

TABLE 247            AUSTRALIA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

 BY TECHNIQUE,  2018–2025 (USD MILLION)         239

TABLE 248            AUSTRALIA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)             239

TABLE 249            AUSTRALIA: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           239

12.6.5    REST OF ASIA PACIFIC    240

TABLE 250            ROAPAC: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

 2018–2025 (USD MILLION)          240

TABLE 251            ROAPAC: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           240

TABLE 252            ROAPAC: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

2018–2025 (USD MILLION)           241

TABLE 253            ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018–2025 (USD MILLION)             241

TABLE 254            ROAPAC: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION) 242

TABLE 255            ROAPAC: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 242

TABLE 256            ROAPAC: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2018–2025 (USD MILLION)             243

TABLE 257            ROAPAC: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018–2025 (USD MILLION)             243

TABLE 258            ROAPAC: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)                243

TABLE 259            ROAPAC: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                244

TABLE 260            ROAPAC: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           244

12.7        COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN THE ASIA PACIFIC               244

12.8        LATIN AMERICA                245

TABLE 261            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 

2018–2025 (USD MILLION)           245

TABLE 262            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

 2018–2025 (USD MILLION)          245

TABLE 263            LATIN AMERICA: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           246

TABLE 264            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          246

TABLE 265            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)       246

TABLE 266            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION)           247

TABLE 267            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION)           247

TABLE 268            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,  BY TYPE, 2018–2025 (USD MILLION) 248

TABLE 269            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)       248

TABLE 270            LATIN AMERICA: LATERAL FLOW ASSAY KITS & REAGENTS MARKET,

 BY TECHNIQUE, 2018–2025 (USD MILLION)          248

TABLE 271            LATIN AMERICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET,

 BY SAMPLE TYPE, 2018–2025 (USD MILLION)      249

TABLE 272            LATIN AMERICA: LATERAL FLOW ASSAYS MARKET, BY END USER, 

2018–2025 (USD MILLION)           249

12.8.1    BRAZIL  249

12.8.1.1                High private healthcare expenditure and increasing geriatric population driving the growth of the lateral flow assays market in the country            249

TABLE 273            BRAZIL: MACROECONOMIC INDICATORS              250

TABLE 274            BRAZIL: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           250

TABLE 275            BRAZIL: LATERAL FLOW READERS MARKET, BY TYPE,

2018–2025 (USD MILLION)           250

TABLE 276            BRAZIL: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          251

TABLE 277            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)             251

TABLE 278            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION) 252

TABLE 279            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 252

TABLE 280            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING,

BY TYPE,  2018–2025 (USD MILLION)        253

TABLE 281            BRAZIL: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)             253

TABLE 282            BRAZIL: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)    253

TABLE 283            BRAZIL: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                254

TABLE 284            BRAZIL: LATERAL FLOW ASSAYS MARKET, BY END USER,

 2018–2025 (USD MILLION)          254

12.8.2    MEXICO               254

12.8.2.1                High prevalence of obesity and related chronic diseases to boost the growth of the lateral flow assays market in the forecast period     254

TABLE 285            MEXICO: MACROECONOMIC INDICATORS           255

TABLE 286            MEXICO: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

 2018–2025 (USD MILLION)          255

TABLE 287            MEXICO: LATERAL FLOW READERS MARKET, BY TYPE,

 2018–2025 (USD MILLION)          255

TABLE 288            MEXICO: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          256

TABLE 289            MEXICO: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018–2025 (USD MILLION)             256

TABLE 290            MEXICO: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION) 257

TABLE 291            MEXICO: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS,  BY TYPE, 2018–2025 (USD MILLION) 257

TABLE 292            MEXICO: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018–2025 (USD MILLION)             258

TABLE 293            MEXICO: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018–2025 (USD MILLION)             258

TABLE 294            MEXICO: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION) 258

TABLE 295            MEXICO: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)                259

TABLE 296            MEXICO: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           259

12.8.3    REST OF LATIN AMERICA              259

TABLE 297            ROLATAM: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,

2018–2025 (USD MILLION)           260

TABLE 298            ROLATAM: LATERAL FLOW READERS MARKET, BY TYPE,

 2018–2025 (USD MILLION)          260

TABLE 299            ROLATAM: LATERAL FLOW ASSAYS MARKET, BY APPLICATION,

 2018–2025 (USD MILLION)          260

TABLE 300            ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,  BY TYPE, 2018–2025 (USD MILLION) 261

TABLE 301            ROLATAM: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING,  BY DISEASE TYPE, 2018–2025 (USD MILLION)       261

TABLE 302            ROLATAM: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION) 262

TABLE 303            ROLATAM: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE,  2018–2025 (USD MILLION)             262

TABLE 304            ROLATAM: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING,  BY TYPE, 2018–2025 (USD MILLION) 262

TABLE 305            ROLATAM: LATERAL FLOW ASSAY KITS & REAGENTS MARKET, BY TECHNIQUE,  2018–2025 (USD MILLION)                263

TABLE 306            ROLATAM: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE,  2018–2025 (USD MILLION)             263

TABLE 307            ROLATAM: LATERAL FLOW ASSAYS MARKET, BY END USER,

2018–2025 (USD MILLION)           263

12.9        COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN LATIN AMERICA  264

12.10     MIDDLE EAST & AFRICA 264

12.10.1  SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANSION OF HEALTHCARE SERVICES IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAYS               264

TABLE 308            AFRICA: MACROECONOMIC INDICATORS             265

TABLE 309            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY PRODUCT,  2018–2025 (USD MILLION)         265

TABLE 310            MIDDLE EAST & AFRICA: LATERAL FLOW READERS MARKET, BY TYPE,

 2018–2025 (USD MILLION)          265

TABLE 311            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY APPLICATION, 20180–2025 (USD MILLION)                266

TABLE 312            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2018–2025 (USD MILLION)           266

TABLE 313            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR INFECTIOUS DISEASE TESTING, BY DISEASE TYPE, 2018–2025 (USD MILLION)               267

TABLE 314            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR SEXUALLY TRANSMITTED INFECTIONS, BY TYPE, 2018–2025 (USD MILLION)               267

TABLE 315            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR CARDIAC MARKER TESTING, BY TYPE, 2020–2025 (USD MILLION)       268

TABLE 316            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET FOR PREGNANCY & FERTILITY TESTING, BY TYPE, 2018–2025 (USD MILLION)           268

TABLE 317            MIDDLE EAST & AFRICA LATERAL FLOW ASSAY KITS & REAGENTS MARKET,  BY TECHNIQUE, 2018–2025 (USD MILLION)             268

TABLE 318            MIDDLE EAST & AFRICA: CLINICAL TESTING LATERAL FLOW ASSAYS MARKET, BY SAMPLE TYPE, 2018–2025 (USD MILLION) 269

TABLE 319            MIDDLE EAST & AFRICA: LATERAL FLOW ASSAYS MARKET, BY END USER,  2018–2025 (USD MILLION)        269

12.11     COVID-19 IMPACT ON THE LATERAL FLOW ASSAYS MARKET IN THE MIDDLE EAST & AFRICA          269

13           COMPETITIVE LANDSCAPE           270

13.1        INTRODUCTION                270

FIGURE 31           KEY DEVELOPMENTS IN THE GLOBAL LATERAL FLOW ASSAYS MARKET,  2018–2020            270

FIGURE 32           MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES DOMINATED THE MARKET BETWEEN 2018 TO 2020       271

13.2        REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS            271

FIGURE 33           TOP MARKET PLAYERS DOMINATE THE LATERAL FLOW ASSAYS MARKET                271

13.3        PRODUCT BENCHMARKING        272

FIGURE 34           PRODUCT PORTFOLIO ANALYSIS: LATERAL FLOW ASSAYS MARKET (2019)              273

13.4        GEOGRAPHICAL ASSESSMENT OF MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET          274

FIGURE 35           GEOGRAPHIC REVENUE MIX: LATERAL FLOW ASSAYS MARKET (2019)      274

13.5        COMPETITIVE ASSESSMENT OF THE R&D EXPENDITURE 275

FIGURE 36           R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAYS MARKET, 2017 VS. 2019        275

13.6        COMPETITIVE SITUATIONS AND TRENDS               275

13.6.1    PRODUCT LAUNCHES     275

TABLE 320            PRODUCT LAUNCHES     275

13.6.2    EXPANSIONS     276

TABLE 321            EXPANSIONS     276

13.6.3    ACQUISITIONS  277

TABLE 322            ACQUISITIONS  277

13.6.4    PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 278

TABLE 323            PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 278

14           COMPANY EVALUATION MATRIX AND COMPANY PROFILES        280

14.1        COMPANY EVALUATION MATRIX DEFINITION & METHODOLOGY              280

14.2        LATERAL FLOW ASSAYS MARKET SHARE (2019)   280

FIGURE 37           LATERAL FLOW ASSAYS MARKET SHARE, BY KEY PLAYER (2019)   280

14.3        COMPETITIVE LEADERSHIP MAPPING     280

14.3.1    STARS   281

14.3.2    EMERGING LEADERS      281

14.3.3    PERVASIVE PLAYERS       281

14.3.4    PARTICIPANTS  281

FIGURE 38           LATERAL FLOW ASSAYS MARKET: COMPANY EVALUATION MATRIX, 2019              282

14.4        COMPETITIVE LEADERSHIP MAPPING FOR START-UPS (2019)      282

14.4.1    PROGRESSIVE COMPANIES         282

14.4.2    DYNAMIC COMPANIES  283

14.4.3    STARTING BLOCKS           283

14.4.4    RESPONSIVE COMPANIES            283

FIGURE 39           LATERAL FLOW ASSAYS MARKET: START-UP COMPANY EVALUATION MATRIX, 2019         283

14.5        COMPANY PROFILES      284

(Business overview, Products offered, Recent developments, SWOT analysis and MNM view)*

14.5.1    ABBOTT LABORATORIES                284

FIGURE 40           ABBOTT LABORATORIES: COMPANY SNAPSHOT (2019)   284

14.5.2    F. HOFFMANN-LA ROCHE AG     290

FIGURE 41           F. HOFFMANN-LA ROCHE AG: COMPANY SNAPSHOT (2019)        290

14.5.3    DANAHER CORPORATION            294

FIGURE 42           DANAHER CORPORATION: COMPANY SNAPSHOT (2019)               294

14.5.4    SIEMENS AG      298

14.5.5    BECTON, DICKINSON AND COMPANY     302

14.5.6    BIOMÉRIEUX SA               306

14.5.7    BIO-RAD LABORATORIES, INC.   309

14.5.8    THERMO FISHER SCIENTIFIC INC.              311

14.5.9    QIAGEN N.V.     315

14.5.10  PERKINELMER INC.          317

FIGURE 49           PERKINELMER INC.: COMPANY SNAPSHOT (2019)             317

14.5.11  HOLOGIC INC.   320

FIGURE 50           HOLOGIC, INC.: COMPANY SNAPSHOT (2019)     320

14.5.12  QUIDEL CORPORATION 322

FIGURE 51           QUIDEL CORPORATION: COMPANY SNAPSHOT (2019)    322

14.5.13  MERCK KGAA    326

FIGURE 52           MERCK KGAA: COMPANY SNAPSHOT (2019)       326

14.5.14  ABCAM PLC        328

FIGURE 53           ABCAM PLC: COMPANY SNAPSHOT (2019)           328

14.5.15  SURMODICS IVD              330

FIGURE 54           SURMODICS IVD: COMPANY SNAPSHOT (2019) 330

14.5.16  CHEMBIO DIAGNOSTIC SYSTEMS, INC.   331

FIGURE 55           CHEMBIO DIAGNOSTIC SYSTEMS, INC.: COMPANY SNAPSHOT (2019)      331

14.5.17  ORASURE TECHNOLOGIES            333

FIGURE 56           ORASURE TECHNOLOGIES: COMPANY SNAPSHOT (2019)               333

14.5.18  DCN DIAGNOSTICS          335

14.5.19  POLYSCIENCES, INC.       335

14.5.20  ABINGDON HEALTH        336

*Details on Business overview, Products offered, Recent developments, SWOT analysis and MNM view might not be captured in case of unlisted companies.

15           APPENDIX           337

15.1        INSIGHTS FROM INDUSTRY EXPERTS       337

15.2        DISCUSSION GUIDE        338

15.3        KNOWLEDGE STORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL  343

15.4        AVAILABLE CUSTOMIZATIONS   345

15.5        RELATED REPORTS           345

15.6        AUTHOR DETAILS             346

 

Lateral Flow Assay Components Market by Type, Application Type (Clinical Testing (Infectious, Cardiac Marker Test) Veterinary, Food Safety), Technique...

Publisher:        MarketsandMarkets

# of Pages:        224

Rating: 

1 User License $4,950

Publication Date:  April, 2022

Price:       $4,950 / User License




1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 CATEGORY-WISE INCLUSIONS AND EXCLUSIONS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 33
1.3 MARKET SCOPE 34
1.3.1 MARKETS COVERED 34
FIGURE 1 LATERAL FLOW ASSAY COMPONENTS MARKET SEGMENTATION 34
1.3.2 YEARS CONSIDERED FOR THE STUDY 35
1.4 CURRENCY 35
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 35
1.5 STAKEHOLDERS 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH APPROACH 36
FIGURE 2 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 36
2.1.1.1 Key data from secondary sources 37
2.1.2 PRIMARY DATA 38
2.1.2.1 Primary sources 38
2.1.2.2 Key data from primary sources 39
2.1.2.3 Breakdown of primaries 39
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE):
BY COMPANY TYPE, DESIGNATION, AND REGION 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 40
2.2 MARKET SIZE ESTIMATION 40
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2021) 41
FIGURE 6 SUPPLY-SIDE ANALYSIS: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 42
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 44
FIGURE 7 DATA TRIANGULATION METHODOLOGY 45
2.4 KEY INDUSTRY INSIGHTS 46
2.5 LIMITATIONS 46
2.5.1 METHODOLOGY-RELATED LIMITATIONS 46
2.6 RISK ASSESSMENT 47
2.7 ASSUMPTIONS FOR THE STUDY 47
 
3 EXECUTIVE SUMMARY 48
FIGURE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2022 VS. 2027 (USD MILLION) 48
FIGURE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 49
FIGURE 10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2022 VS. 2027 (USD MILLION) 50
FIGURE 11 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2022 VS. 2027 (USD MILLION) 51
FIGURE 12 GEOGRAPHICAL SNAPSHOT OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 52
4 PREMIUM INSIGHTS 53
4.1 LATERAL FLOW ASSAY COMPONENTS MARKET OVERVIEW 53
FIGURE 13 RISING NUMBER OF LOCAL MANUFACTURERS FOR COMPONENTS IS DRIVING THE GROWTH OF THE LATERAL FLOW ASSAY COMPONENTS MARKET 53
4.2 REGIONAL MIX: LATERAL FLOW ASSAY COMPONENTS MARKET 54
FIGURE 14 APAC TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 54
4.3 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE AND COUNTRY 55
FIGURE 15 MEMBRANES ACCOUNTED FOR THE LARGEST SHARE OF THE ASIA PACIFIC MARKET IN 2021 55
4.4 LATERAL FLOW ASSAY COMPONENTS MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 56
4.5 LATERAL FLOW ASSAY COMPONENTS MARKET: DEVELOPED VS. DEVELOPING COUNTRIES 56
5 MARKET OVERVIEW 57
5.1 INTRODUCTION 57
5.2 MARKET DYNAMICS: IMPACT ANALYSIS 57
5.2.1 DRIVERS 58
5.2.1.1 Growing demand for lateral flow assay kits due
to the COVID-19 pandemic 58
5.2.1.2 Growing usage of home-based lateral flow assay devices 58
5.2.1.3 Growing demand for point-of-care testing 58
5.2.1.4 Increasing public-private investments to develop lateral flow assays 59
5.2.2 RESTRAINTS 59
5.2.2.1 Availability of alternative diagnostic technologies 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Evolving applications of lateral flow assays 59
5.2.4 CHALLENGES 60
5.2.4.1 Requirement of specialized storage and shipping facilities for membranes 60
5.3 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES (YC-YCC) IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 60
FIGURE 16 YC–YCC SHIFT IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 61
5.5 AVERAGE SELLING PRICE TREND 61
TABLE 2 AVERAGE SELLING PRICE OF LATERAL FLOW ASSAY COMPONENTS,
BY REGION, 2021 (USD) 61
5.6 ECOSYSTEM MARKET MAP 62
FIGURE 17 ECOSYSTEM: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 62
5.7 PATENT ANALYSIS 63
5.7.1 PATENT PUBLICATION TRENDS FOR LATERAL FLOW ASSAYS 63
FIGURE 18 GLOBAL PATENT PUBLICATION TRENDS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2016–2021 64
5.7.2 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 64
FIGURE 19 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR LATERAL FLOW ASSAYS COMPONENTS, 2016–2021 64
5.8 VALUE CHAIN ANALYSIS 65
5.9 REGULATORY LANDSCAPE 66
TABLE 3 REGULATORY STANDARDS/APPROVALS REQUIRED FOR LATERAL FLOW IMMUNOASSAY PRODUCTS, BY COUNTRY/REGION 66
5.9.1 NORTH AMERICA 66
5.9.2 EUROPE 67
5.9.3 ASIA PACIFIC 67
5.9.3.1 India 67
5.9.3.2 China 67
5.9.3.3 Japan 68
5.10 TECHNOLOGY ANALYSIS 69
5.10.1 KEY TECHNOLOGY: LATERAL FLOW ASSAYS 69
5.11 KEY CONFERENCES & EVENTS DURING 2021–2023 69
TABLE 4 LATERAL FLOW ASSAY COMPONENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS 69
5.12 KEY STAKEHOLDERS & BUYING CRITERIA 70
5.12.1 KEY STAKEHOLDERS IN THE BUYING PROCESS 70
FIGURE 20 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
TABLE 5 INFLUENCE OF STAKEHOLDERS IN THE BUYING PROCESS FOR THE TOP 3 APPLICATIONS 70
5.12.2 BUYING CRITERIA 71
FIGURE 21 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
TABLE 6 KEY BUYING CRITERIA FOR THE TOP 3 APPLICATIONS 71
5.13 PORTER’S FIVE FORCES ANALYSIS 72
TABLE 7 LATERAL FLOW ASSAY COMPONENTS MARKET:
PORTER’S FIVE FORCES ANALYSIS 72
5.13.1 THREAT FROM NEW ENTRANTS 72
5.13.2 THREAT FROM SUBSTITUTES 72
5.13.3 BARGAINING POWER OF BUYERS 73
5.13.4 BARGAINING POWER OF SUPPLIERS 73
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 73
6 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE 74
6.1 INTRODUCTION 75
TABLE 8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 75
6.2 MEMBRANES 75
TABLE 9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE,
2020–2027 (USD MILLION) 76
TABLE 10 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 76
6.2.1 NITROCELLULOSE MEMBRANES 77
6.2.1.1 Advantages of nitrocellulose membranes such as high protein-binding affinity and compatibility with a wide range of detection methods to drive market growth 77
TABLE 11 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES, BY COUNTRY, 2020–2027 (USD MILLION) 77
TABLE 12 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (1 X 1 M SHEETS), BY REGION, 2020–2027 (IN THOUSANDS) 78
TABLE 13 LATERAL FLOW ASSAY COMPONENTS MARKET FOR NITROCELLULOSE MEMBRANES (20 MM X 1 M ROLLS), BY REGION, 2020–2027 (IN MILLIONS) 78
6.2.2 OTHER MEMBRANES 78
TABLE 14 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER MEMBRANES,
BY COUNTRY, 2020–2027 (USD MILLION) 79
6.3 PADS 80
TABLE 15 EXAMPLES OF DIFFERENT MATERIALS USED IN MANUFACTURING LATERAL FLOW ASSAY PADS 80
TABLE 16 LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 80
TABLE 17 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PADS, BY COUNTRY, 2020–2027 (USD MILLION) 81
6.3.1 SAMPLE PADS 81
6.3.1.1 Ability to promote even and controlled distribution of samples to drive market growth 81
TABLE 18 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SAMPLE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 82
6.3.2 CONJUGATE PADS 82
6.3.2.1 Conjugate pads play an important role in controlling the performance of lateral flow immunoassays 82
TABLE 19 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CONJUGATE PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 83
6.3.3 ABSORBENT PADS 84
6.3.3.1 Absorbent pads prevent backflow—a key factor driving market growth 84
TABLE 20 LATERAL FLOW ASSAY COMPONENTS MARKET FOR ABSORBENT PADS,
BY COUNTRY, 2020–2027 (USD MILLION) 84
6.4 OTHER COMPONENTS 84
TABLE 21 OTHER LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 85
7 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION 86
7.1 INTRODUCTION 87
TABLE 22 LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 87
7.2 CLINICAL TESTING 87
TABLE 23 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 88
TABLE 24 LATERAL FLOW ASSAYS MARKET FOR CLINICAL TESTING APPLICATIONS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
7.2.1 INFECTIOUS DISEASE TESTING 89
7.2.1.1 Rising demand for infectious disease testing in emerging markets to drive market growth 89
TABLE 25 LATERAL FLOW ASSAY COMPONENTS MARKET FOR INFECTIOUS DISEASE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 89
7.2.2 PREGNANCY & FERTILITY TESTING 90
7.2.2.1 Growing infertility levels due to changing lifestyles—a key factor driving market growth 90
TABLE 26 LATERAL FLOW ASSAY COMPONENTS MARKET FOR PREGNANCY & FERTILITY TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 90
7.2.3 CARDIAC MARKER TESTING 91
7.2.3.1 Rising prevalence of cardiovascular diseases and growing government support to drive growth in this market segment 91
TABLE 27 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CARDIAC MARKER TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 92
7.2.4 CHOLESTEROL TESTING/LIPID PROFILING 92
7.2.4.1 Growing prevalence of obesity and CVD—
a key factor driving market growth 92
TABLE 28 LATERAL FLOW ASSAY COMPONENTS MARKET FOR CHOLESTEROL TESTING/LIPID PROFILING, BY COUNTRY, 2020–2027 (USD MILLION) 93
7.2.5 DRUGS-OF-ABUSE TESTING 93
7.2.5.1 Technological advancements and a growing focus on workplace
drug testing are driving market growth 93
TABLE 29 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUGS-OF-ABUSE TESTING, BY COUNTRY, 2020–2027 (USD MILLION) 94
7.2.6 OTHER CLINICAL TESTING APPLICATIONS 94
TABLE 30 LATERAL FLOW ASSAY COMPONENTS MARKET FOR OTHER CLINICAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 95
7.3 VETERINARY DIAGNOSTICS 95
7.3.1 INFECTIOUS DISEASE OUTBREAKS (PARTICULARLY IN LARGE LIVESTOCK ANIMALS) TO DRIVE MARKET GROWTH 95
TABLE 31 LATERAL FLOW ASSAY COMPONENTS MARKET FOR VETERINARY DIAGNOSTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 96
7.4 FOOD SAFETY & ENVIRONMENTAL TESTING 96
7.4.1 HIGH SENSITIVITY AND EASE OF USE ARE KEY FACTORS DRIVING THE DEMAND FOR LATERAL FLOW ASSAYS FOR FOOD SAFETY TESTING 96
TABLE 32 LATERAL FLOW ASSAY COMPONENTS MARKET FOR FOOD SAFETY & ENVIRONMENTAL TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 97
7.5 DRUG DEVELOPMENT & QUALITY TESTING 97
7.5.1 INCREASING FOCUS ON PRODUCT SAFETY AND QUALITY ASSURANCE TO DRIVE MARKET GROWTH IN THE COMING YEARS 97
TABLE 33 LATERAL FLOW ASSAY COMPONENTS MARKET FOR DRUG DEVELOPMENT & QUALITY TESTING APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 98
8 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE 99
8.1 INTRODUCTION 100
TABLE 34 LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 100
8.2 SANDWICH ASSAYS 100
8.2.1 SANDWICH ASSAYS PROVIDE HIGHER LEVELS OF ASSAY SENSITIVITY AND SPECIFICITY THAN OTHER ASSAY TECHNIQUES—A KEY FACTOR DRIVING GROWTH IN THIS MARKET SEGMENT 100
TABLE 35 LATERAL FLOW ASSAY COMPONENTS MARKET FOR SANDWICH ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 COMPETITIVE ASSAYS 101
8.3.1 REDUCED SELECTIVITY AND SENSITIVITY OF COMPETITIVE ASSAYS IN RELATION TO SANDWICH ASSAYS COULD HAMPER MARKET GROWTH 101
TABLE 36 LATERAL FLOW ASSAY COMPONENTS MARKET FOR COMPETITIVE ASSAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 102
8.4 MULTIPLEX DETECTION ASSAYS 102
8.4.1 INCREASING ADOPTION OF MULTI-ANALYTE ASSAYS AMONG CLINICIANS TO DRIVE MARKET GROWTH 102
TABLE 37 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MULTIPLEX DETECTION ASSAYS, BY COUNTRY, 2020–2027 (USD MILLION) 103
9 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER 104
9.1 INTRODUCTION 105
TABLE 38 LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 105
9.2 MEDICAL DEVICE MANUFACTURING COMPANIES 105
9.2.1 INCREASING USE OF POC TESTS IS DRIVING THE ADOPTION OF LATERAL FLOW ASSAY COMPONENTS AMONG MEDICAL DEVICE MANUFACTURING COMPANIES 105
TABLE 39 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE MANUFACTURING COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 106
9.3 MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES 106
9.3.1 GROWING INCLINATION TOWARD FAST AND EARLY DIAGNOSIS, ESPECIALLY IN RELATION TO THE CURRENT COVID-19 SCENARIO, WILL DRIVE MARKET GROWTH 106
TABLE 40 LATERAL FLOW ASSAY COMPONENTS MARKET FOR MEDICAL DEVICE CONTRACT MANUFACTURING COMPANIES, BY COUNTRY,
2020–2027 (USD MILLION) 107
 
10 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION 108
10.1 INTRODUCTION 109
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH IN THE LATERAL FLOW ASSAY COMPONENTS MARKET DURING THE FORECAST PERIOD 109
TABLE 41 LATERAL FLOW ASSAY COMPONENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 110
10.2 NORTH AMERICA 110
TABLE 42 NORTH AMERICA: MACROECONOMIC INDICATORS 110
FIGURE 23 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 111
TABLE 43 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 44 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 112
TABLE 45 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 112
TABLE 46 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 113
TABLE 47 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 113
TABLE 48 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 49 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 114
TABLE 50 NORTH AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 115
10.2.1 US 115
10.2.1.1 Increasing R&D investments and venture capital funding from both large and small firms towards the development of lateral flow assay diagnostics to drive market growth in the US 115
TABLE 51 US: MACROECONOMIC INDICATORS 116
TABLE 52 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 116
TABLE 53 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 116
TABLE 54 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 117
TABLE 55 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 117
TABLE 56 US: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 118
TABLE 57 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 118
TABLE 58 US: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 119
10.2.2 CANADA 119
10.2.2.1 Lateral flow assay components market in Canada is estimated to grow at a relatively lower rate than the US 119
TABLE 59 CANADA: MACROECONOMIC INDICATORS 119
TABLE 60 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 120
TABLE 61 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 120
TABLE 62 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 120
TABLE 63 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 121
TABLE 64 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 121
TABLE 65 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 122
TABLE 66 CANADA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
10.3 EUROPE 122
TABLE 67 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 123
TABLE 68 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 123
TABLE 69 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 123
TABLE 70 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 124
TABLE 71 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 124
TABLE 72 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 125
TABLE 73 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 125
TABLE 74 EUROPE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 126
10.3.1 GERMANY 126
10.3.1.1 Growing demand for POC testing to drive the lateral flow assay components market in Germany 126
TABLE 75 GERMANY: MACROECONOMIC INDICATORS 126
TABLE 76 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 127
TABLE 77 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 127
TABLE 78 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 127
TABLE 79 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 128
TABLE 80 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 128
TABLE 81 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 129
TABLE 82 GERMANY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 129
10.3.2 FRANCE 129
10.3.2.1 High prevalence of age-related chronic diseases and infectious diseases to drive market growth in France 129
TABLE 83 FRANCE: MACROECONOMIC INDICATORS 130
TABLE 84 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 130
TABLE 85 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 130
TABLE 86 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 131
TABLE 87 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 131
TABLE 88 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 132
TABLE 89 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 132
TABLE 90 FRANCE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 133
10.3.3 UK 133
10.3.3.1 Severe impact of the second wave of COVID-19 in the first half of 2021 resulted in higher adoption of rapid COVID tests in the UK 133
TABLE 91 UK: MACROECONOMIC INDICATORS 134
TABLE 92 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 134
TABLE 93 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 134
TABLE 94 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 135
TABLE 95 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION,
2020–2027 (USD MILLION) 135
TABLE 96 UK: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 97 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 98 UK: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.3.4 ITALY 137
10.3.4.1 Growing initiatives towards decentralization of medical services in Italy are contributing to the market growth in the country 137
TABLE 99 ITALY: MACROECONOMIC INDICATORS 137
TABLE 100 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 138
TABLE 101 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 138
TABLE 102 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 138
TABLE 103 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 139
TABLE 104 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 105 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 140
TABLE 106 ITALY: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 140
10.3.5 SPAIN 140
10.3.5.1 Increasing focus of international organizations and domestic players on the development of POC products in the country to drive market growth 140
TABLE 107 SPAIN: MACROECONOMIC INDICATORS 141
TABLE 108 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 141
TABLE 109 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 142
TABLE 110 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 142
TABLE 111 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 142
TABLE 112 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 113 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 143
TABLE 114 SPAIN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 144
10.3.6 REST OF EUROPE 144
TABLE 115 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 144
TABLE 116 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 145
TABLE 117 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 145
TABLE 118 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 145
TABLE 119 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 146
TABLE 120 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 146
TABLE 121 ROE: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 147
10.4 ASIA PACIFIC 147
FIGURE 24 ASIA PACIFIC: LATERAL FLOW ASSAY COMPONENTS MARKET SNAPSHOT 148
TABLE 122 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 149
TABLE 123 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 149
TABLE 124 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 149
TABLE 125 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 150
TABLE 126 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 150
TABLE 127 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 128 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 151
TABLE 129 APAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 152
10.4.1 CHINA 152
10.4.1.1 Higher exports of lateral flow assay components during the COVID-19 pandemic to drive market growth in the country 152
TABLE 130 CHINA: MACROECONOMIC INDICATORS 153
TABLE 131 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 153
TABLE 132 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 153
TABLE 133 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 154
TABLE 134 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
TABLE 135 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 136 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 155
TABLE 137 CHINA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 156
10.4.2 JAPAN 156
10.4.2.1 Increasing prevalence of age-related illnesses driving the growth of the lateral flow assay components market in Japan 156
TABLE 138 JAPAN: MACROECONOMIC INDICATORS 157
TABLE 139 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 157
TABLE 140 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 157
TABLE 141 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 158
TABLE 142 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 158
TABLE 143 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 144 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 159
TABLE 145 JAPAN: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 160
10.4.3 INDIA 160
10.4.3.1 Increasing number of local manufacturers, growing healthcare concerns, and rising income levels to propel the growth of this market 160
TABLE 146 INDIA: MACROECONOMIC INDICATORS 160
TABLE 147 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 161
TABLE 148 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 161
TABLE 149 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE,
2020–2027 (USD MILLION) 161
TABLE 150 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 162
TABLE 151 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 162
TABLE 152 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 163
TABLE 153 INDIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.4 AUSTRALIA 164
10.4.4.1 Increasing prevalence of infectious diseases, especially influenza, to drive the growth of the lateral flow assay components market in Australia 164
TABLE 154 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 164
TABLE 155 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 164
TABLE 156 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 165
TABLE 157 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 165
TABLE 158 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 159 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 160 AUSTRALIA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.5 REST OF ASIA PACIFIC 167
TABLE 161 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE,
2020–2027 (USD MILLION) 167
TABLE 162 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 168
TABLE 163 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD TYPE, 2020–2027 (USD MILLION) 168
TABLE 164 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 168
TABLE 165 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 169
TABLE 166 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 169
TABLE 167 ROAPAC: LATERAL FLOW ASSAY COMPONENTS MARKET, BY END USER, 2020–2027 (USD MILLION) 170
 
10.5 LATIN AMERICA 170
10.5.1 HIGH DEMAND FOR HIV POC DEVICES IN THE REGION TO SUPPORT THE GROWTH OF THE MARKET 170
TABLE 168 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 169 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 171
TABLE 170 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET, BY PAD
TYPE, 2020–2027 (USD MILLION) 171
TABLE 171 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 172
TABLE 172 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 172
TABLE 173 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 173
TABLE 174 LATIN AMERICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 173
10.6.1 SIGNIFICANT SUPPORT FROM GOVERNMENTS AND GLOBAL FIRMS TOWARDS EXPANDING HEALTHCARE SERVICES DRIVES THE ADOPTION OF LATERAL FLOW ASSAYS 173
TABLE 175 MIDDLE EAST & AFRICA: MACROECONOMIC INDICATORS 174
TABLE 176 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 177 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY MEMBRANE TYPE, 2020–2027 (USD MILLION) 175
TABLE 178 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY PAD TYPE, 2020–2027 (USD MILLION) 175
TABLE 179 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY APPLICATION, 2020–2027 (USD MILLION) 175
TABLE 180 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET FOR CLINICAL TESTING APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 176
TABLE 181 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY TECHNIQUE, 2020–2027 (USD MILLION) 176
TABLE 182 MIDDLE EAST & AFRICA: LATERAL FLOW ASSAY COMPONENTS MARKET,
BY END USER, 2020–2027 (USD MILLION) 177
11 COMPETITIVE LANDSCAPE 178
11.1 OVERVIEW 178
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 178
FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
11.3 REVENUE SHARE ANALYSIS FOR KEY PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 179
FIGURE 26 REVENUE SHARE ANALYSIS FOR THE KEY PLAYERS
IN THE LATERAL FLOW ASSAY COMPONENTS MARKET 180
11.4 MARKET SHARE ANALYSIS 180
FIGURE 27 LATERAL FLOW ASSAY COMPONENTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2021) 181
TABLE 183 LATERAL FLOW ASSAY COMPONENTS MARKET: DEGREE OF COMPETITION 182
11.5 R&D ASSESSMENT OF KEY PLAYERS 183
FIGURE 28 R&D EXPENDITURE: MAJOR PLAYERS IN THE LATERAL FLOW ASSAY COMPONENTS MARKET, 2018 VS. 2020 183
11.6 GEOGRAPHIC REVENUE ASSESSMENT OF KEY PLAYERS 183
FIGURE 29 GEOGRAPHIC REVENUE ASSESSMENT: LATERAL FLOW ASSAY COMPONENTS MARKET (2021) 184
11.7 COMPANY EVALUATION QUADRANT 184
11.7.1 STARS 184
11.7.2 PERVASIVE PLAYERS 184
11.7.3 EMERGING LEADERS 185
11.7.4 PARTICIPANTS 185
FIGURE 30 LATERAL FLOW ASSAY COMPONENTS MARKET: COMPANY EVALUATION MATRIX, 2021 185
11.8 COMPETITIVE BENCHMARKING 186
11.8.1 OVERALL COMPANY FOOTPRINT 186
TABLE 184 OVERALL COMPANY FOOTPRINT (17 COMPANIES) 186
TABLE 185 COMPANY FOOTPRINT: BY TYPE (17 COMPANIES) 187
TABLE 186 COMPANY FOOTPRINT: BY REGION (17 COMPANIES) 188
11.9 COMPETITIVE SCENARIO 188
11.9.1 DEALS 189
TABLE 187 DEALS, JANUARY 2019–FEBRUARY 2022 189
11.9.2 OTHER DEVELOPMENTS 189
TABLE 188 OTHER DEVELOPMENTS, JANUARY 2019–FEBRUARY 2022 189
12 COMPANY PROFILES 190
12.1 KEY PLAYERS 190
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER CORPORATION (PALL CORPORATION AND CYTIVA LIFE SCIENCE) 190
TABLE 189 DANAHER CORPORATION: BUSINESS OVERVIEW 190
FIGURE 31 DANAHER CORPORATION: COMPANY SNAPSHOT (2020) 191
12.1.2 SARTORIUS STEDIM BIOTECH 195
TABLE 190 SARTORIUS STEDIM BIOTECH: BUSINESS OVERVIEW 195
12.1.3 MERCK KGAA 199
TABLE 191 MERCK KGAA: BUSINESS OVERVIEW 199
FIGURE 33 MERCK KGAA: COMPANY SNAPSHOT (2020) 200
12.1.4 AHLSTROM-MUNKSJÖ 204
TABLE 192 AHLSTROM-MUNKSJÖ: BUSINESS OVERVIEW 204
FIGURE 34 AHLSTROM-MUNKSJÖ: COMPANY SNAPSHOT (2020) 205
12.1.5 ADVANCED MICRODEVICES PVT. LTD. 208
TABLE 193 ADVANCED MICRODEVICES PVT. LTD.: BUSINESS OVERVIEW 208
12.1.6 DCN DIAGNOSTICS 210
TABLE 194 DCN DIAGNOSTICS: BUSINESS OVERVIEW 210
12.2 OTHER PLAYERS 211
12.2.1 FORTIS LIFE SCIENCES 211
TABLE 195 FORTIS LIFE SCIENCES: BUSINESS OVERVIEW 211
12.2.2 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD 212
TABLE 196 HANGZHOU COBETTER FILTRATION EQUIPMENT CO. LTD.:
BUSINESS OVERVIEW 212
12.2.3 AXIVA SICHEM BIOTECH 214
TABLE 197 AXIVA SICHEM BIOTECH: BUSINESS OVERVIEW 214
12.2.4 NUPORE FILTRATION SYSTEM 216
TABLE 198 NUPORE FILTRATION SYSTEM: BUSINESS OVERVIEW 216
12.2.5 BALLYA BIO 217
TABLE 199 BALLYA BIO: BUSINESS OVERVIEW 217
12.2.6 RUNBIO BIOTECH CO. LTD. 219
TABLE 200 RUNBIO BIOTECH CO. LTD.: BUSINESS OVERVIEW 219
12.2.7 NEENAH GESSNER 220
TABLE 201 NEENAH GESSNER: BUSINESS OVERVIEW 220
12.2.8 MAXIM BIOMEDICAL 221
TABLE 202 MAXIM BIOMEDICAL: BUSINESS OVERVIEW 221
12.2.9 CYTODIAGNOSTICS 222
TABLE 203 CYTODIAGNOSTICS: BUSINESS OVERVIEW 222
12.2.10 SENOVA GMBH 223
TABLE 204 SENOVA GMBH: BUSINESS OVERVIEW 223
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 224
13.1 DISCUSSION GUIDE 224
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 229
13.3 AVAILABLE CUSTOMIZATIONS 231
13.4 RELATED REPORTS 231
13.5 AUTHOR DETAILS 232

US Healthcare Environmental Services Market by Type (Janitorial/Core-Cleaning, Infection Control & Prevention, Front-of-house cleaning & Brand Experie...

Publisher:        MarketsandMarkets

# of Pages:        126

Rating: 

1 User License $4,950

Publication Date:  March, 2022

Price:       $4,950 / User License




1 INTRODUCTION 15
1.1 OBJECTIVES OF THE STUDY 15
1.2 MARKET DEFINITION & SCOPE 15
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 16
1.2.2 MARKET SEGMENTATION 16
FIGURE 1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET SEGMENTATION 16
1.2.3 YEARS CONSIDERED FOR THE STUDY 17
1.3 CURRENCY 17
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 17
1.4 STAKEHOLDERS 18
2 RESEARCH METHODOLOGY 19
2.1 RESEARCH APPROACH 19
FIGURE 2 RESEARCH DESIGN 19
2.1.1 SECONDARY RESEARCH 20
2.1.1.1 Key data from secondary sources 21
2.1.2 PRIMARY RESEARCH 21
FIGURE 3 PRIMARY SOURCES 22
2.1.2.1 Key data from primary sources 23
2.1.2.2 Insights from primary experts 23
2.1.2.3 Breakdown of primary interviews 24
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE (SUPPLY & DEMAND SIDE) AND DESIGNATION 24
2.2 MARKET SIZE ESTIMATION 25
FIGURE 5 MARKET SIZE APPROACH – REVENUE SHARE ANALYSIS 25
FIGURE 6 CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 26
FIGURE 7 DEMAND-SIDE APPROACH 28
2.3 DATA TRIANGULATION 29
FIGURE 8 DATA TRIANGULATION METHODOLOGY 29
2.4 MARKET RANKING ANALYSIS 30
2.5 ASSUMPTIONS FOR THE STUDY 30
2.6 LIMITATIONS 31
2.6.1 METHODOLOGY-RELATED LIMITATIONS 31
2.6.2 SCOPE-RELATED LIMITATIONS 31
2.7 RISK ASSESSMENT 31
TABLE 2 RISK ASSESSMENT: US HEALTHCARE ENVIRONMENTAL SERVICES MARKET 31
 
3 EXECUTIVE SUMMARY 32
FIGURE 9 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 32
FIGURE 10 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET,
BY FACILITY TYPE, 2021 VS. 2026 (USD MILLION) 33
4 PREMIUM INSIGHTS 34
4.1 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET OVERVIEW 34
FIGURE 11 STRINGENT REGULATORY GUIDELINES ON INFECTION CONTROL & PREVENTION METHODS IS A KEY FACTOR DRIVING THE MARKET GROWTH 34
4.2 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE AND FACILITY TYPE 35
FIGURE 12 JANITORIAL/CORE-CLEANING SERVICES ACCOUNTED FOR THE LARGEST SHARE OF THE US HEALTHCARE ENVIRONMENTAL SERVICES
MARKET IN 2020 35
4.3 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE (2021–2026) 36
FIGURE 13 ACUTE CARE FACILITIES TO DOMINATE THE US HEALTHCARE ENVIRONMENTAL SERVICES MARKET DURING THE FORECAST PERIOD 36
5 MARKET OVERVIEW 37
5.1 INTRODUCTION 37
5.2 MARKET DYNAMICS 37
TABLE 3 MARKET DYNAMICS: HEALTHCARE ENVIRONMENTAL SERVICES MARKET 37
5.2.1 MARKET DRIVERS 38
5.2.1.1 Increasing prevalence of Hospital-acquired infections (HAIs) 38
5.2.1.2 Rising number of hospital admissions and surgeries 39
TABLE 4 US: PERCENTAGE INCREASE IN THE NUMBER OF SURGERIES PERFORMED 39
FIGURE 14 TOTAL ADMISSIONS IN ALL US HOSPITALS 40
FIGURE 15 TOTAL NUMBER OF HOSPITALS IN THE US 40
5.2.1.3 Shortage of in-house expertise and the rising need to reduce healthcare costs 41
5.2.1.4 Increasing outsourcing of cleaning services 41
5.2.2 MARKET RESTRAINTS 41
5.2.2.1 Healthcare facilities with an in-house EVS department 41
5.2.3 MARKET OPPORTUNITIES 42
5.2.3.1 Sustained acquisitions among strategic & financial buyers 42
TABLE 5 COMPANY ACQUISITIONS 42
5.2.4 MARKET CHALLENGES 42
5.2.4.1 Noncompliance with cleaning standards by EVS providers 42
5.3 INDUSTRY TRENDS 43
5.3.1 EMERGENCE OF NEW SURFACE DISINFECTANTS &
GREEN CLEANING PRODUCTS 43
5.3.2 DISINFECTION ROBOTS 44
5.3.3 MONITORING TOOLS FOR CLEANING QUALITY ASSESSMENT 44
5.4 TECHNOLOGY ANALYSIS 45
TABLE 6 TECHNOLOGY INNOVATION IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 45
5.5 PATENT ANALYSIS 45
5.5.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE ENVIRONMENTAL SERVICES 46
FIGURE 16 PATENT PUBLICATION TRENDS (JANUARY 2011–DECEMBER 2021) 46
5.5.2 JURISDICTION AND TOP APPLICANT ANALYSIS 47
FIGURE 17 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 47
FIGURE 18 TOP APPLICANT COUNTRIES/REGIONS FOR HEALTHCARE ENVIRONMENTAL SERVICES PATENTS (JANUARY 2011–JANUARY 2022) 48
TABLE 7 LIST OF PATENTS/PATENT APPLICATIONS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET, 2020–2021 48
5.6 IMPACT OF COVID-19 ON THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 50
6 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE 51
6.1 INTRODUCTION 52
TABLE 8 US: HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY TYPE,
2019–2026 (USD MILLION) 52
6.2 JANITORIAL SERVICES/CORE-CLEANING SERVICES 52
6.2.1 MANDATORY REGULAR CLEANING AND DISINFECTION OF HEALTHCARE FACILITIES TO DRIVE THE MARKET GROWTH 52
6.3 INFECTION PREVENTION & CONTROL SERVICES 53
TABLE 9 US: INFECTION PREVENTION & CONTROL SERVICE MARKET, BY TYPE,
2019–2026 (USD MILLION) 53
6.3.1 SPECIALIZED CLEANING SERVICES 53
6.3.1.1 Rising adoption of specialized services to reduce HAIs to drive the market growth 53
6.3.2 INFECTION PREVENTION & CONTROL CONSULTATION SERVICES 53
6.3.2.1 The provision of customized environmental services specific
to a healthcare facility ensures market demand 53
6.4 ENHANCED CLEANING TECHNOLOGY 54
6.4.1 RISING DEMAND FOR ADVANCED CLEANING SOLUTIONS TO DRIVE THE SEGMENT GROWTH 54
TABLE 10 EXAMPLES OF COMPANIES PROVIDING TECHNOLOGY & INNOVATION IN HEALTHCARE EVS 54
6.5 FRONT-OF-HOUSE CLEANING AND BRAND EXPERIENCE 56
6.5.1 RISING AWARENESS TOWARDS A CLEAN AND SAFE ENVIRONMENT DURING PANDEMICS TO SUSTAIN THE MARKET GROWTH 56
6.6 OTHER SERVICES 56
 
7 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE 57
7.1 INTRODUCTION 58
FIGURE 19 STATES WITH THE HIGHEST NUMBER OF COVID-19 ADMISSIONS
(FEBRUARY 2022) 58
TABLE 11 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET, BY FACILITY TYPE, 2019–2026 (USD MILLION) 59
7.2 ACUTE-CARE FACILITIES 59
TABLE 12 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR ACUTE-CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 59
7.2.1 ACUTE HOSPITALS 60
7.2.1.1 Increasing hospital admissions due to COVID-19 and the rising prevalence of HAIs propel the market growth 60
FIGURE 20 NUMBER OF HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS
IN THE US (2020) 60
FIGURE 21 HAIS REPORTED BY GENERAL ACUTE CARE HOSPITALS IN THE US (2020) 61
FIGURE 22 HAIS REPORTED BY CRITICAL ACCESS HOSPITALS (CAHS) IN THE US (2018) 61
7.2.2 MILITARY TREATMENT FACILITY 61
7.2.2.1 The increasing number of military ambulatory health services & funding to drive the market growth 61
FIGURE 23 MILITARY HEALTH SYSTEMS FACILITIES IN THE US (2021) 62
7.2.3 CHILDREN’S HOSPITALS 62
7.2.3.1 Rising cases of COVID-19 and infection-related mortality rates among children drive the market growth 62
7.2.4 AMBULATORY SURGERY CENTERS (ASCS) 63
7.2.4.1 ASCs save time and reduce the risk of HAIS; key factor driving the market growth 63
FIGURE 24 US SURGERY CASES BY SETTING: ASC VS. HOPD (2005-2020) 64
7.2.5 ACADEMIC MEDICAL CENTERS (AMCS) 64
7.2.5.1 Healthcare capacity expansion during COVID-19 drives the adoption of healthcare environmental services in AMCs 64
7.3 POST-ACUTE CARE FACILITIES 64
TABLE 13 US: HEALTHCARE ENVIRONMENTAL SERVICES FOR POST-ACUTE CARE SETTINGS, BY TYPE 2019–2026 (USD MILLION) 65
7.3.1 LONG-TERM ACUTE HOSPITALS (LTACH) 65
7.3.1.1 Increasing risk of infection due to prolonged hospital stays to drive the market growth 65
7.3.2 SKILLED NURSING FACILITIES (SNF) 66
7.3.2.1 Increasing admissions of elderly people in skilled nursing facilities to drive the market growth 66
7.3.3 OTHER POST-ACUTE CARE FACILITIES 66
7.4 NON-ACUTE CARE FACILITIES 67
TABLE 14 US: ENVIRONMENTAL SERVICES MARKET FOR NON-ACUTE CARE SETTINGS, BY TYPE, 2019–2026 (USD MILLION) 67
7.4.1 PHYSICIAN’S OFFICES AND CLINICS 67
7.4.1.1 High patient traffic leads to continuous cleaning & maintenance to drive the market growth 67
7.4.2 OTHER NON-ACUTE CARE FACILITIES 68
FIGURE 25 DISTRIBUTION OF INDUSTRY MEDICAL AND HEALTH R&D INVESTMENTS,
BY SEGMENT (2020) 68
8 COMPETITIVE LANDSCAPE 70
8.1 OVERVIEW 70
8.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 70
8.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE HEALTHCARE ENVIRONMENTAL SERVICES MARKET 71
8.3 REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS 72
8.4 MARKET RANKING ANALYSIS 73
FIGURE 27 US HEALTHCARE ENVIRONMENTAL SERVICE MARKET RANKING,
BY KEY PLAYER, 2020 73
8.5 COMPETITIVE BENCHMARKING 75
TABLE 15 FOOTPRINT OF COMPANIES IN THE HEALTHCARE ENVIRONMENTAL
SERVICES MARKET 75
TABLE 16 SERVICE FOOTPRINT OF COMPANIES 76
TABLE 17 END-USER FOOTPRINT OF COMPANIES 77
8.6 COMPETITIVE LEADERSHIP MAPPING 77
8.6.1 STARS 78
8.6.2 EMERGING LEADERS 78
8.6.3 PERVASIVE PLAYERS 78
8.6.4 PARTICIPANTS 78
FIGURE 28 US HEALTHCARE ENVIRONMENTAL SERVICES MARKET:
COMPETITIVE LEADERSHIP MAPPING (2021) 79
8.7 COMPETITIVE SCENARIO 80
8.7.1 SERVICE APPROVALS/ENHANCEMENTS 80
8.7.2 DEALS 81
TABLE 19 DEALS, 2018–2022 81
8.7.3 OTHER DEVELOPMENTS 82
9 COMPANY PROFILES 83
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
9.1 SODEXO GLOBAL 83
TABLE 21 SODEXO GLOBAL: BUSINESS OVERVIEW 83
FIGURE 29 SODEXO GLOBAL: COMPANY SNAPSHOT (2021) 84
9.2 COMPASS GROUP (CROTHALL HEALTHCARE (US)) 87
TABLE 22 COMPASS GROUP: BUSINESS OVERVIEW 87
FIGURE 30 COMPASS GROUP: COMPANY SNAPSHOT (2021) 88
 
9.3 ARAMARK CORPORATION 90
TABLE 23 ARAMARK CORPORATION: BUSINESS OVERVIEW 90
FIGURE 31 ARAMARK CORPORATION: COMPANY SNAPSHOT (2021) 91
9.4 HOSPITAL HOUSEKEEPING SYSTEMS (HHS) (US) 94
TABLE 24 HOSPITAL HOUSEKEEPING SYSTEMS (HHS): BUSINESS OVERVIEW 94
9.5 HEALTHCARE SERVICES GROUP, INC. 97
TABLE 25 HEALTHCARE SERVICES GROUP, INC.: BUSINESS OVERVIEW 97
FIGURE 32 HEALTHCARE SERVICES GROUP: COMPANY SNAPSHOT (2020) 98
9.6 ABM INDUSTRIES INCORPORATED 100
TABLE 26 ABM INDUSTRIES INCORPORATED: BUSINESS OVERVIEW 100
FIGURE 33 ABM INDUSTRIES INCORPORATED: COMPANY SNAPSHOT (2020) 101
9.7 OCTOCLEAN 103
TABLE 27 OCTOCLEAN: BUSINESS OVERVIEW 103
9.8 SERVICEMASTER CLEAN (SERVICEMASTER TBS) 105
TABLE 28 SERVICEMASTER CLEAN.: BUSINESS OVERVIEW 105
9.9 CORVUS JANITORIAL SYSTEMS 107
TABLE 29 CORVUS JANITORIAL SYSTEMS: BUSINESS OVERVIEW 107
9.10 BRAVO! BUILDING SERVICES 109
TABLE 30 BRAVO! BUILDING SERVICES: BUSINESS OVERVIEW 109
9.11 POWERLINK ENVIRONMENTAL SERVICES, LLC 111
TABLE 31 POWERLINK ENVIRONMENTAL SERVICES, LLC: BUSINESS OVERVIEW 111
9.12 JANI-KING INTERNATIONAL, INC. 112
TABLE 32 JANI- KING INTERNATIONAL, INC: BUSINESS OVERVIEW 112
9.13 AVI FOOD SYSTEMS(US) 114
TABLE 33 AVI FOOD SYTEMS, INC.: BUSINESS OVERVIEW 114
9.14 SERVICON 115
TABLE 34 SERVICON: BUSINESS OVERVIEW 115
9.15 XANITOS, INC. 117
TABLE 35 XANITOS, INC.: BUSINESS OVERVIEW 117
9.16 STATHAKIS 119
TABLE 36 STATHAKIS: BUSINESS OVERVIEW 119
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
10 APPENDIX 120
10.1 INSIGHTS FROM INDUSTRY EXPERTS 120
10.2 DISCUSSION GUIDE 121
10.3 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 124
10.4 AVAILABLE CUSTOMIZATIONS 126
10.5 RELATED REPORTS 126
10.6 AUTHOR DETAILS 127